Wadsworth, IL, United States of America

Roger L Deaton

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Abbott Laboratories Corporation. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roger L Deaton. Retrieved from https://idiyas.com/inventor/roger-l-deaton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roger L. Deaton and His Patent on Tiagabine for Pain Treatment.

Introduction

Roger L. Deaton is an inventor associated with Wadsworth, Illinois, United States. His recorded patent work concerns the use of tiagabine for treating pain associated with diabetic neuropathy and migraine.

Latest Patents

Deaton is credited with 1 patent: “Use of Tiagabine for Treatment of Diabetic Neuropathy and Migraine.” The patent describes (R)-N-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid and its salts as GABA uptake inhibitory compounds with pharmacological effects on pain associated with diabetic neuropathy and migraine.

Career Highlights

Deaton’s listed company affiliation is Abbott Laboratories Corporation. His patent reflects research into the potential therapeutic applications of compounds that inhibit GABA uptake.

Collaborations

Deaton’s listed coworkers include Stephen D. Collins and William J. Giardina.

Conclusion

Roger L. Deaton’s recorded invention connects GABA uptake inhibition with potential treatment approaches for pain associated with diabetic neuropathy and migraine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…